1. Introduction
Deltamethrin (DLT, decamethrin) is a cyclopropanecarboxylate ester obtained by formal condensation between 3-(2,2-dibromovinyl)-2,2-dimethylcyclopanecarboxylic acid and cyano(3-phenoxyphenyl)methanol [1,2]. It is viewed to be the active insecticide of the proinsecticide tralomethrin [3,4,5]. Pyrethroids like DLT or tefluthrin (Tef) have been demonstrated to modify the gating characteristics of voltage-gated Na+ (NaV) channels [6,7,8,9,10]. Deltamethrin (DLT), a neurotoxic type-II pyrethroid ester insecticide [3,4,5], has been demonstrated previously to cause a reversible sequence of motor symptoms in rats involving hind limb rigidity and choreoathetosis [2,11,12,13]. Alternatively, DLT was also reported to decrease Cl− currents through voltage-dependent Cl− channels and this action probably contributes the most to the features of poisoning with DLT or other type II pyrethroids [14,15,16]. At relatively high concentrations, pyrethroids can also act on GABA-gated Cl− channels, which may be responsible for the seizures seen with severe type-II poisoning [2,17].
It has been established that nine isoforms (i.e., NaV1.1–1.9 [or SCN1A–SCN5A and SCN8A–SCN11A]) of the voltage-gated Na+ (NaV) channels are widely distributed in mammalian excitable tissues, which include the central or peripheral nervous system, and the endocrine or neuroendocrine system [18,19,20]. The eukaryotic versions of these NaV-channel proteins are comprised of a single subunit which contains four six-transmembrane pseudodomains [20,21]. Upon rapid depolarization, the NaV channels, by which macroscopic voltage-gated Na+ currents (INa) are encoded, are characterized by going through rapid transitions from the closed (resting) state to the open state, and then by swiftly changing to the inactivated state [20,21]. The inactivation of INa has been also demonstrated to accumulate before being stimulated during repetitive short depolarizing pulses [22,23,24,25]. Consequently, once being evoked, the increased magnitude of INa can quickly depolarize the cell membrane through positive feedback cycle and, in turn, elicit the upstroke of the action potentials, thereby intrinsically governing the amplitude, frequency, and/or pattern of firing action potentials, as well as hormonal secretion, in an array of excitable cells [20,21,26,27]. On the other hand, the aberrant changes in NaV (i.e., NaV1.2) channel activity occurring in corticostriatal circuits of adult mice were also reported to elevate neuronal excitability [28].
Like the action of tefluthrin (Tef) [7,8,16,26,29], deltamethrin (DLT) was used to kill a wide range of insects [2,6,30]. There is a growing concern over human or animal poisoning as aberrant use in these esters. However, whether and how deltamethrin (DLT) or other structurally similar pyrethroids (e.g., Tef) is able to modify the magnitude, gating kinetics, frequency dependence, and/or voltage-dependent hysteresis (Hys(V)) of INa remains mostly obscure, although they are recognized to augment the INa magnitude [6,7,8,9].
In light of the aforementioned considerations, we wanted to extensively explore the electrophysiological effects of DLT and other related compounds (e.g., Tef) in pituitary GH3 sommatolactotrophs with either a single voltage-clamp pulse or pulse train (PT) stimulation. The tetrodotoxin (TTX)-sensitive INa, which is responsible for the generation of action potentials, has been identified in pituitary tumor (GH3) cells [18]. The GH3 cell line has been demonstrated previously to express the α-subunits of NaV1.1, NaV1.2, NaV1.3, and NaV1.6, as well as the β1 and β3-subunits of NaV channel [18,31]. In the current investigations, we intended to (1) evaluate if DLT has any perturbations on the peak (transient, INa(T)) and sustained (late, INa(L)) components of INa intrinsically in these cells; (2) examine if this compound affects either magnitude or time course of INa during as well as following 1-s pulse train (PT) stimulation; (3) explore whether or not the Hys(V)’s behavior of persistent INa (INa(P)) could be seriously disturbed by the presence of DLT; and (4) the molecular docking between the DLT molecule and the hNaV1.5 channel was also predicted. The present results disclosed that the differential and dose-dependent stimulation of INa(T) and INa(L) by DLT as well as its perturbations either on INa occurring during or following PT stimulation, or on Hys(V) properties of INa(P) may potentially converge to engage in a great impact on electrical behaviors of mammalian excitable cells (e.g., GH3 cells).
2. Results
2.1. Modification by Deltamethrin (DLT) or Tefluthrin (Tef) on Voltage-Gated Na+ Current (INa) Measured from Pituitary GH3 Cells
In the first stage of whole-cell current recordings, we measured the effects of DLT or Tef on the magnitude and inactivation time course of INa activated in response to abrupt depolarizing pulse. We placed cells in Ca2+-free, Tyrode’s solution containing 10 mM tetraethylammonium chloride (TEA), and the pipette used was filled up with a Cs+-containing solution. As demonstrated in Figure 1A, two minutes after cells were continually exposed to DLT or Tef at a concentration of 10 μM, the amplitude in the transient (INa(T)) or late (INa(L)) component of INa activated by 20-ms depolarizing pulse from −80 to −10 mV was progressive raised. For example, as the rectangular voltage step from −80 to −10 mV with a duration of 20 ms was given (indicated in the uppermost part of Figure 1A) to activate INa, the addition of 10 μM DLT was found to result in a striking increase in either INa(T) or INa(L) amplitude to 512 ± 17 pA (n = 9, p < 0.05) or 128 ± 9 pA (n = 9, p < 0.05) from control values of 401 ± 15 or 22 ± 5 pA (n = 9), respectively. After washout of DLT, INa(T) or INa(L) was returned to 409 ± 17 or 28 ± 7 pA (n = 9). Likewise, the presence of 10 μM Tef also measurably increased INa(T) or INa(L) amplitude from 409 ± 14 pA (n = 9) or 32 ± 6 pA (n = 9) to 499 ± 16 pA (n = 9, p < 0.05) or 162 ± 11 pA (n = 9, p < 0.05), respectively. However, with cell exposure to 10 μM DLT, neither fast nor slow time constant of INa(T) inactivation in response to rapid membrane depolarization was evidently changed. Alternatively, with the presence of 10 μM Tef, the slow component in the time constant of INa(T) inactivation was strikingly raised to 19 ± 2 msec (n = 9, p < 0.05) from a control value of 0.9 ± 0.2 msec (n = 9). The time course of effects of DLT (10 μM) on the amplitude of INa(Tot), INa(L) or INa(T) is illustrated in Figure 1B. Of note, during exposure to 10 mM DLT, the amplitude of INa(Tot), INa(L), or INa(T) was increased to 177 ± 21 % (n = 8), 1752 ± 105 % (i.e., around 1.7-fold) (n = 8), or 24 ± 6% (n = 8), respectively.
Figure 1C demonstrates that the addition of DLT to the bath can concentration-dependently increase the amplitude of INa(T) or INa(L) activated by short depolarizing step. According to the Hill equation stated under Materials and Methods, the EC50 value needed for DLT-stimulated INa(T) or INa(L) observed in GH3 cells was calculated as 11.2 or 2.5 µM, respectively. Consistent with previous studies [6,8], the experimental observations, therefore, enable us to reflect that the DLT presence exerts a stimulatory action on the magnitude of INa(T) and INa(L) natively expressed in GH3 cells, and that this compound tends to be selective for INa(L) over INa(T) during rectangular depolarizing pulse.
2.2. Comparison among Effects of Tef, DLT, Tef plus Chlorotoxin (ChloroTx), DLT plus ChloroTx, Tef plus Dapaglifozin (Dapa), DLT plus Dapa, and DLT plus Amiloride on INa(L) Amplitude Measured from GH3 Cells
Exposure to pyrethroids (e.g., DLT) has been previously demonstrated to activate Cl− currents [14,15,16]. We further compared the effects of Tef, DLT or their combinations with ChloroTx, Dapa, or amiloride on INa(L) amplitude. ChloroTx was reported to suppress Cl− current, Dapa was an inhibitor of INa(L) [32,33], and amiloride can attenuate the pyrethroids-stimulated sodium transport [16]. As summarized in Figure 2, with continued presence of Tef or DLT, the further exposure to ChloroTx (1 μM) failed to modify their stimulation of INa(L). Dapa (10 mM) or amiloride (10 mM) alone decrease the INa(L) amptitude to 31 ± 2 pA (n = 8, p < 0.05) or 28 ± 2 pA (n = 8, p < 0.05) from control value of 50.3 ± 3 pA (n = 8). Moreover, the subsequent presence of either Dapa (10 μM) or amiloride (10 μM) was able to attenuate Tef- or DLT-mediated increase of INa(L) effectively. The results prompted us to suggest that either Dapa or amiloride could directly cause an inhibitory effect on the amplitude of INa(L) observed in GH3 cells [32,33].
2.3. Effect of DLT on Mean Current Versus Voltage (I-V) Relationship of INa(T) and INa(L)
We next explored any perturbations of this compound on the amplitude of INa(T) or INa(L) measured from the different level of membrane potentials. As demonstrated in Figure 3A,B, a steady-state I-V relationship of INa(T) and INa(L) acquired with or without the DLT (10 μM) presence was established in these cells. The appearance of 10 μM DLT resulted in a striking increase in the INa(T) or INa(L) amplitude elicited by abrupt depolarizing steps. For example, when the tested cells were rapidly depolarized from −80 to −10 mV, the addition of 10 μM DLT raised either INa(T) or INa(L) magnitude from 729 ± 54 to 952 ± 76 pA (n = 8, p < 0.05), or from 26 ± 34 to 265 ± 48 pA (n = 8, p < 0.05), respectively. However, the steady-state I-V relationship of INa(T) or INa(L) remained unaffected during exposure to 10 μM DLT, despite a marked increase in INa(T) or INa(L) magnitude. The relationship (i.e., G-V relationship) for the conductance of INa(T) or INa(L)) with or without the application of 10 μM DLT was also established and depicted in Figure 3C. The V1/2 value for G-V relationship of INa(T) or INa(L) between the absence and presence of 10 mM DLT did not differ significantly {(−19.9 ± 1.8 mV [control] versus −20.5 ± 1.7 mV [in the presence of DLT]; n = 8, p > 0.05, for the results of INa(T)), or (−18.4 ± 1.6 mV [control] versus −18.5 ± 1.6 mV [in the presence of DLT]; n = 8, p > 0.05, for the results of INa(L))}.
2.4. Tef- or DLT-Mediated Slowing in Cumulative Inhibition of INa(T) during Rapid Depolarizing Stimuli
It has been demonstrated that, prior to being activated during repetitive short pulses, the inactivation of INa(T) is able to accumulate [22,23,25,34,35,36]. For this reason, we next explored if Tef or DLT could modify the extent of INa(T) activated either during or following the PT depolarizing stimuli. In this set of measurement, the stimulus protocol, consisting of repetitive depolarization of −10 mV (20 ms in each pulse with a rate of 40 Hz for 1 s), was applied to the tested cells which were voltage-clamped at −80 mV. In accordance with earlier reports [22,23,24,25,36], as demonstrated in Figure 4 and Figure 5, during the control period (i.e., neither Tef nor DLT was present), the exponential time course of INa(T) inactivation observed in GH3 cells was observed during a 1-s repetitive depolarization from −80 to −10 mV, and an evolving decaying time constant of 22.1 ± 2.8 ms (n = 8) was then yielded. In other words, there appeared to be a progressive current decay (indicated with the dashed arrows in Figure 4A) with a single-exponential process. It also needs to be noted that with cell exposure to DLT (10 μM), the time constant of INa(T) decaying activated during the same train of depolarizing pulses was increased to 56.4 ± 3.9 ms (n = 8), apart from a progressive increase in INa(L) or INa(Tail) (i.e., appearance of tail current following 1-s PT stimulation) magnitude. Of additional notice, a significant increase in tail INa (INa(Tail)) (blue open triangles in Figure 5) with a rising time constant of 87.4 ± 4.6 ms (n = 8) was found in the presence of 10 μM DLT (Figure 4B,C and Figure 5); however, cell exposure to 10 μM Tef resulted in a gradual decay in INa(L) with a decaying time constant of 26.3 ± 2.7 ms (n = 8). Alternatively, with continued exposure to 10 mM DLT, further addition of Dapa (10 mM) or Ami (10 mM) significantly decreased the time constant of INa(L) during PT stimulation. Table 1 summarizes the results showing effects of DLT, DLT plus dapagliflozin (Dapa), DLT plus amiloride (Ami) on either the decaying time constant of INa(T) during PT stimulation or the rising time constant of INa(L) during the same PT stimulation, as well as the time constant of INa(Tail) recovery evoked following PT stimulation.
Moreover, with the DLT presence, an exponential increase in INa(L) during PT stimuli occurring over time was also observed (Figure 4B,C). Following 1-s PT stimulation, as cells were continually exposed to 10 μM DLT, there appeared to be a large inward current (i.e., INa(Tail)) accompanied by a gradual recovery (indicated with asterisk in Figure 4B) in the second timescale with a recovery time constant of 1.23 ± 0.19 s (n = 8) (Figure 4B,C). The appearance of INa(Tail) could reflect changes in the magnitude of INa(P), and the INa(L) and INa(P) evoked during an extended period of time were thought to share the same NaV channels [22,26]. Likewise, with the presence of 10 μM Tef, the recovery time constant of INa(Tail)) (or INa(P)) acquired following PT stimuli was estimated to be 123 ± 25 ms (n = 8), a value which is different from DLT-induced change in the recovery time constant of INa(Tail) following PT stimuli. In contrast, during the control period (i.e., neither Tef nor DLT was present), the recovery time constant of the current following PT stimulation was rather small (i.e., 25 ± 3 ms [n = 8]) (Figure 6B). Moreover, with continued presence of DL (10 mM), further addition of either Dapa (10 mM) or Ami (10 mM) significantly attenuated the recovery time constant of INa(T) evoked following PT stimulation, as summarized in Table 1.
Additionally, with continued exposure to Tef (10 μM) or DLT (10 μM), further addition of dapagliflozin (Dap) at a concentration of 10 μM resulted in an attenuation of the drastic appearance of large inward INa(Tail) following PT stimuli, as demonstrated by a respective reduction in the recovery time constant of the current to 54 ± 17 ms (n = 8, p < 0.05) or 564 ± 62 ms (n = 8, p < 0.05) estimated during further presence of Dapa (10 μM) (Figure 6B). Taken together, these results prompted us to reflect that the presence of DLT can act as a striking slowing the deactivating kinetics of INa(Tail) (or INa(P)) following return to the holding potential at −80 mV. Therefore, during 1-s PT stimulation, insufficient period of time was allowed for INa recovery. As a result, particularly during exposure to DLT, single INa deactivation during PT stimulation presently given (i.e., at a rate of 40 Hz) could be apparently incomplete, thereby leading to frequency-dependent ‘accumulation’ of the NaV-channel activated state. Therefore, the response of Tef- and DLT-mediated INa(L) or INa(Tail) was overly distinguishable. In other words, one (i.e., the Tef presence) is progressive decay of INa(L) during a train of depolarizing pulses, while the other (i.e., the DLT presence) exhibits a staircase increase in INa(L). Moreover, upon continued exposure to 10 μM DLT, the subsequent addition of Dapa (10 μM) could measurably attenuate DLT-mediated increase INa(Tail) during PT stimuli as well as shortened the recovery time constant of INa(P) following repetitive depolarizing stimuli (Figure 6A,B).
2.5. Effect of Tef or DLT on the Strength of Voltage-Dependent Hysteresis (Hys(V)) of Persistent INa (INa(P)) Elicited by an Upright Isosceles-Triangular Ramp Voltage (Vramp)
The nonlinear Hys(V) behavior residing in INa(P) has been recently disclosed with a figure-of-eight (i.e., -shaped) configuration as current traces were robustly activated by an upright double Vramp (i.e., ascending and descending limbs of triangular Vramp) [33]. In this regard, efforts were made to explore if the existence of Tef or DLT could have any different adjustments on the Hys(V)’s behavior elicited in response to such upright Vramp. This separate set of measurements was performed in GH3 cells which were placed in Ca2+-free Tyrode’s solution, and we filled up the measuring electrodes with a solution containing Cs+. The tested cells were maintained at −80 mV and an upright double Vramp ranging between −80 and +50 mV for a duration of 1 s (i.e., ramp speed of ±0.26 mV/ms) was afterwards applied to them. As shown in Figure 7A, during cell exposure to Tef (10 μM) or DLT (10 μM), current traces in response to such triangular Vramp are distinguishable, although two types of hysteretic loops (i.e., low- and high-threshold loops) became overly noticeable during the presence of Tef or DLT. In particular, the strength of low-threshold hysteretic loop during such Vramp became considerably larger in the presence of Tef (10 μM), as compared with that during exposure to DLT. For example, as cells were continually exposed to Tef (10 μM), the amplitude of INa(P) at the descending limb of Vramp (i.e., at the level of −70 mV) resulted in a striking increase by 6.6 folds from 61 ± 9 to 403 ± 24 pA (n = 8, p < 0.05); conversely, upon the presence of DLT (10 μM), INa(P) amplitude at the same level was increased only by 1.5 folds (Figure 7C). However, upon cell exposure to Tef (10 μM) or DLT (10 μM), the INa(P) amplitude at the ascending limb (i.e., at −10 mV) was increased to 3.6 or 3.7 folds, respectively, which did not differ significantly between these two compounds. From these data, it was plausible to assume that the strength of INa(P)’s Hys(V) in response to long-lasting double Vramp was susceptible to being enhanced during Tef or DLT presence; moreover, the low-threshold loop of Hys(V) appeared to be more sensitive to augmentation by Tef than that by DLT.
3. Discussion
In the current investigations together with previous studies, we provided the evidence to unveil that the presence of DLT, known to be a type II pyrethroid, was able to exert stimulatory actions on vastly different types of INa, including INa(T), INa(L), INa(Tail), and INa(P), seen in pituitary tumor (GH3) cells. It is likely, therefore, that the endocrine disrupting potential caused by the existence of DLT or other structurally similar pyrethroids, as demonstrated recently [2,16,20,27,37,38,39,40,41], could be highly linked to the excitatory actions on varying types of INa presented herein, presuming that similar pharmacological or toxicological actions take place in variable types of endocrine or neuroendocrine cells present in vivo [2,3,7,11,13,42], although pyrethroids are thought to be around 2250 times more toxic than mammals [12,13].
Upon cell exposure to DLT, the observed INa(L) activated in response to short depolarizing step was noticed to be stimulated to a greater extent than the INa(T). The EC50 values required for DLT-stimulated INa(T) and INa(L) in GH3 cells were estimated to be 11.2 and 2.5 μM, these values which was noted to differ significantly by 4.5 folds (Figure 1). However, the further addition of chlorotoxin (ChloroTx), still in continued presence of tefluthrin (Tef) or DLT, failed to modify Tef- or DLT-stimulated INa(L), although either dapagliflozin (Dapa) or amiloride could effectively reverse their increase in INa(L) amplitude. Tef is a Type I pyrethroid insecticide [8,10,26]. The overall steady-state I-V relationship of INa(T) or INa(L) during exposure to DLT remained unchanged; furthermore, the inactivation time course of INa(T) during brief step depolarizing did not differ between the absence and presence of DLT. However, the magnitude of INa(T) following the PT stimulation (i.e., 40-Hz repetitive depolarizing pulse) tended to be pronouncedly larger as well as its decaying time course became slowed in the presence of Tef or DLT (Figure 4).
It needs to be mentioned that a large appearance of inward current (i.e., INa(P)) following such PT stimulation clearly emerged during the presence of Tef or DLT, while a rather small transient current following the same PT stimuli was observed during the control conditions (i.e., neither Tef nor DLT was present). The larger magnitude of inward current immediately following PT stimuli by adding DLT was noted as compared to that by Tef. Furthermore, the exposure to Tef markedly rendered the inactivation time course of INa(T) during rapid membrane depolarization to become slowed, whereas DLT itself had minimal interference with the inactivation time constant of the current. However, the DLT existence, a progressive elevation of INa(L) and INa(Tail) during a train of repetitive depolarizations; moreover, it induced a larger tail INa following repetitive depolarizations. The experimental results can be interpreted to mean that, upon continued exposure to DLT, the INa deactivation elicited during PT stimuli could be apparently incomplete, thus leading to rate-dependent ‘accumulation’ of the NaV channel activated state. The slowed inactivation caused by the exposure to Tef thus reflects that the barrier for going from the open to the inactivated state of the NaV channel tends to be higher during its presence. The α-cyano-3-phenoxybenzyl group present in the DLT molecule tends to be a notable structure required preferentially for open/resting state of the channel.
Earlier reports have demonstrated the effectiveness of DLT either in inducing the raise in Ca2+ transient or exert anti-neoplastic actions in different types of neoplastic cells, including liver, oral, and prostate cancer cells, and Jurkat-J6 cell cells [43,44,45,46,47,48]. The functional expression of NaV channels has also been reported in different neoplastic cells, including prostate cancer and glioma cells [45,49,50,51,52]. As such, whether DLT-mediated modifications on INa presented herein can be responsible for the actions of DLT or other structurally similar pyrethroids on intracellular Ca2+ or aberrant growth in neoplastic cells [44] is worth pursuing further.
Earlier reports have demonstrated the effectiveness of pyrethroids (e.g., DLT, esfenvalerate, or permethrin) in increasing long-term potentiation recorded in CA1 hippocampal region [53,54,55,56]. Indeed, a brief period of high-frequency electrical activity applied artificially to a neuronal pathway is expected to enhance the strength of synapses for various periods of time, which is called long-term potentiation. However, it needs to be stressed that with cell exposure to either Tef or DLT, following 1-s PT stimulation from −80 to −10 mV, a large inward current (i.e., INa(P)) with slowly decaying process was considerably observed (Figure 4A,B). Under such scenario, the observed induction of long-term potentiation (i.e., facilitation of synaptic transmitter [e.g., glutamate] release) evoked during high-frequency stimulation could have been seriously disturbed or even overestimated by the present findings showing a large recovery time course of INa emerging following PT stimulation in situations where cells present in tissue preparations were exposed to either Tef or DLT.
Previous studies have demonstrated that pyrethroids could affect transepithelial ion transport in the external layers of the skin and the further addition of amiloride could regulate pyrethroids-mediated change in such transepithelial ion transport [16,57]. In this study, the subsequent addition of amiloride can attenuate DLT-induced increase in INa(L) measured from GH3 cells; however, further application of chlorotoxin (ChloroTx) had no effect on DLT- or Tef-stimulated INa. Moreover, further addition of ChloroTx failed to modify changes in DLT- or Tef-stimulated INa during PT timulation; however, subsequent application of either Dapa or amiloride could significantly attenuate DLT and Tef-stimulated INa by the same stimulation protocol. Therefore, the amiloride-mediated effect on the modifications by pyrethroids of ion transport through rabbit skin is likely associated with its direct inhibitory action on INa(L).
The ability of pyrethroids (e.g., DLT) to augment Cl− currents has been previously demonstrated [14,16]. In our study, the subsequent addition of ChloroTx, an inhibitor of Cl− currents, failed to modify DLT-stimulated INa(T) or INa(L) in GH3 cells (Figure 2). However, the further application of dapagliflozin (Dapa) or amiloride can effectively attenuate DLT-activated INa(L) or INa(P). Dapa was recently demonstrated to ameliorate Tef-augmented Hys(V) strength of INa(P) activated by double Vramp [33]. Therefore, DLT-mediated stimulation of INa(T), INa(L), and INa(P) demonstrated herein is unlikely to be attributed to its activation of Cl− current.
Work in our laboratory has demonstrated the non-equilibrium Hys(V) behavior of INa(P) activated by the upright isosceles-triangular Vramp [33]. The results indicated that there was a striking voltage dependence of such Vramp-evoked INa(P) [29,33]. The experimental data also showed two types of Hys(V) loops (i.e., a high-threshold counterclockwise followed by a low-threshold clockwise loop) with a figure-of-eight () configuration, which is reminiscent of the dynamics of the Lorenz-like motion [58]. Alternatively, with GH3-cell exposure to Tef or DLT, the Hys(V) motion of INa(P) activated by the upsloping (ascending) and downsloping (descending) ends of such double Vramp as a function of time was noticed to move in both counterclockwise and clockwise directions (Figure 7A). In particular, one activated during the ascending limb of double Vramp is called a high-threshold counterclockwise loop with a peak of around −10 mV, while the other evoked by the descending limb of Vramp is a low-threshold clockwise loop with a peak falling at around −70 mV [33]. Moreover, as compared with the effect of DLT on Hys(V)’s strength of INa(P), the exposure to Tef could augment Hys(V)’s strength at low-threshold loop to a greater extent than that observed at high-threshold loop. However, with continued presence of either Tef or DLT, the further addition of Dapa could attenuate their stimulation of Hys(V) strength in GH3 cells. Thus, the presence of Tef could slow the inactivation time course of INa(T) activated by rapid step depolarization as well as augment magnitude of INa(P)’s low-threshold loop of Hys(V) responding to double Vramp. Conversely, as cells were exposed to DLT, the INa(T) inactivation time course during step depolarization was found to remain unchanged, and the increased strength of low-threshold Hys(V) loop during double Vramp was relatively smaller in its presence. It is therefore plausible to assume that the low-threshold loop of INa(P)’s Hys(V) activated during the downsloping end of double Vramp could be closely linked to the extent of the inactivation time course of INa(T).
4. Conclusions
The modifications by DLT and Tef on the magnitude, gating kinetics, frequency dependence, and Hys(V) strength of INa in electrically excitable cells are noticeably different. The variable actions of pyrethroids presented here would be of clinical, pharmacological, and toxicological relevance [3].
5. Materials and Methods
5.1. Chemicals, Drugs, Reagents, and Solution Used in This Work
Deltamethrin (DLT, decamethrin, C22H19Br2NO3, IUPAC name: [(S)-cyano-(3-phenoxyphenyl)methyl](1R,3R)-3-(2,2-dibromoethenyl)-2,2-dimethylcyclopropane-1-carboxylate, (S)-α-cyano-3-phenoxybenzyl-cis-(1R,3R)-3(2,2-dibromovinyl)(2,2-dimethyl-cyclopropane-carboxylate) was acquired from MedChemExpress (Asia Biomed Inc., Taipei, Taiwan), dapagliflozin (Dapa, Foxiga®) was from Cayman (Ann Arbo, MI), while amiloride, tetraethylammonium chloride (TEA), tetrodotoxin (TTX), and tefluthrin (Tef) were from Sigma-Aldrich (Genechain, Kaohsiung, Taiwan). Chlorotoxin was a kind gift from Professor Dr. Woei-Jer Chuang (Department of Biochemistry, National Cheng Kung University Medical College, Tainan, Taiwan). Because of a highly nonpolar nature of low water solubility (Laskowski, 2002), the stock solution of DLT (10 mM) was prepared by dissolving it in dimethylsulfoxide (DMSO), and it was wrapped in aluminum foil and then kept under −20 °C for long-term storage. Unless specified otherwise, growth media (e.g., Ham’s F-12 medium), fetal or horse bovine serum, trypsin/EDTA, and L-glutamine were mostly acquired from HyCloneTM (Thermo Fisher, Kaohsiung, Taiwan), while other chemicals or reagents were from Sigma-Aldrich or Merck (Genechain), and they were of laboratory grade and taken from standard sources.
The standard extracellular solution (i.e., normal Tyrode’s solution) used in this study had the ionic compositions containing (in mM): NaCl 136.5, CaCl2 1.8, KCl 5.4, MgCl2 0.53, glucose 5.5, HEPES 5.5, and the solution pH was titrated to 7.4 by adding NaOH. The composition of Ca2+-free Tyrode’s solution used for the measurement of INa (e.g., INa(T), INa(L), INa(P), and INa(Tail)) was the same as normal Tyrode’s solution in which CaCl2 was removed. For the experiments on recording INa, the electrode used was filled up with the internal pipette solution containing (in mM): Cs-aspartate 130, CsCl 20, KH2PO4 1. MgCl2, Na2ATP 3, Na2GTP 0.1, and HEPES 5, and the pH was then adjusted to 7.2 with CsOH. The twice-distilled water used for the experiments was deionized with a Milli-Q ion exchange and activated carbon cartridge treatment system (Merck, Tainan, Taiwan).
5.2. Cell Preparation
Clonal pituitary (GH3) somatolactotrophs, originally acquired from the Bioresources Collection and Research Center ([BCRC-60015],
5.3. Electrophysiological Measurements (Patch-Clamp Current Recordings)
In the few hours before the experiments, GH3 cells were detached from culture dishes with a 1% trypsin/EDTA solution, and a few drops of cell suspension (~106/mL) was rapidly placed in a custom-built chamber mounted on the stage of a DM-IL inverted phase-contrast microscope (Leica; Major Instruments, Kaohsiung, Taiwan). We bathed cells at room temperature (20–25 °C) in the extracellular solution (i.e., normal Tyrode’s solution), the ionic compositions of which are described above. Before each experiment, cells were allowed to settle on the chamber’s bottom. The recording pipettes were pulled from Kimax®-51 borosilicate glass tube (#DWK34500-99; Kimble®, Merck, Tainan, Taiwan) and they were then polished to reach the resistances ranging between 3 and 5 MΩ. During each measurement, the electrode was mounted in an air-tight holder, which had a suction port on the side, and a silver-chloride wire was used to make good contact with the internal pipette solution. We recorded varying types of ionic currents (e.g., INa) with the whole-cell mode of a modified patch-clamp technique by using an RK-400 patch amplifier (Bio-Logic, Claix, France), as dealt with in our previous works [26,36,59]. All recordings were conducted inside a noise-proof Faraday cage. The junction potentials that commonly develop when the compositions of the pipette internal solution are different from those in the bath were zeroed shortly before giga-Ω formation was made, and the whole-cell data were corrected. As pulse train (PT) stimulation was applied to the tested cell, we used an Astro-Med Grass S88X dual output pulse stimulator (Grass; KYS Technology, Tainan, Taiwan).
5.4. Data Recordings and Processing
Throughout the recording period, the signal output (i.e., potential and current traces) was monitored and digitized online at 10 kH or more in an ASUS ExpertBook laptop computer (Yuan-Dai, Tainan, Taiwan). For analog-to-digital (A/D) and digital-to-analog (D/A) conversion, a Digidata® 1550B converter equipped with the computer was controlled by pCLAMPTM 10.6 program run under Microsoft Windows 7 (Redmond, WA, USA). Current signals were low-pass filtered at 2 kHz by using a FL-4 four-pole Bessel filter (Dagan, Minneapolis, MN, USA). The voltage-clamp protocols with manifold rectangular or ramp waveforms were designed, and they were then given to the examined cell through D/A conversion.
5.5. Data Analyses for Whole-Cell Ionic Currents
To establish concentration-dependent stimulation of DLT on the amplitude of INa(T) or INa(L), we bathed GH3 cells in Ca2+-free Tyrode’s solution which contained 10 mM tetraethylammonium chloride (TEA). During the recording period, we voltage-clamped each cell at −80 mV, and a brief step depolarization to −10 mV for a 20 ms at a rate 0.2 Hz was applied to evoke INa. The INa(T) magnitude was measured as the peak amplitude of INa at the beginning of depolarizing pulse was subtracted from the sustained INa (i.e., INa(L)), while the INa(L) magnitude was measured at the end of 20-ms depolarizing pulse in situations where different DLT concentrations were cumulatively given (as indicated in the right side of Figure 1A). The total amplitude of INa (INa(Tot)) taken from each step depolarization is equal to INa(T) plus INa(L). The amplitude of INa(L) obtained during the presence of DLT at a concentration of 100 µM was considered as 100% and we then compared current magnitudes (i.e., INa(T) and INa(L)) during cell exposure to varying concentrations of DLT. The concentration-dependent stimulation by DLT of INa(T) or INa(L) observed in GH3 cells was determined by fitting experimental data set to a modified Hill function [10,25], which can be given as follows.
In this equation, [DLT] = the deltamethrin (DLT) concentration given; nH = the Hill coefficient (i.e., coefficient for cooperativity); EC50 = the concentration required for a 50% stimulation of INa(T) or INa(L) amplitude activated in response to short depolarizing step from −80 to −10 mV; and Emax = maximal stimulation of INa(T) or INa(L) produced by the DLT presence.
5.6. Curve-Fitting Approximations and Statistical Analyses Used in This Work
To determine the model parameters, linear or nonlinear curve-fitting to the experimental data set presently obtained was optimally fitted with least-squares minimization procedure by using manifold analytical tools, such as the Microsoft “Solver” built in Excel® 2022 (Microsoft) and OriginPro® 2022 program (OriginLab®; Scientific Formosa, Kaoshiung, Taiwan). The experimental results are presented as the mean ± standard error of the mean (SEM). The size of independent observations (n) is indicated in cell numbers collected during the measurements. The data distribution obtained presently was found to satisfy the tests for normality. Paired or unpaired t-tests were used for comparison between the two different groups; however, for comparison among more than two groups, we carried out analysis of variance (for one- or two-way ANOVA) with or without repeated measure followed by a post hoc Fisher’s least-significance difference test for multiple-range comparisons. A statistical significance (indicated with *, **, +, or ++ in the figures) was considered when p < 0.01 or < 0.05.
Conceptualization, S.-N.W., M.-H.L., J.-F.L., C.-L.W., H.-Y.C. and M.-C.Y.; Methodology, S.-N.W.; Software, S.-N.W.; Validation, M.-H.L., J.-F.L., C.-L.W., M.-C.Y., H.-Y.C. and S.-N.W.; Formal analysis, S.-N.W.; Investigation, M.-C.Y. and S.-N.W.; Resources, S.-N.W.; Data curation, S.-N.W.; Writing—original draft preparation, S.-N.W.; Writing—review and editing, M.-H.L., J.-F.L., C.-L.W., H.-Y.C., M.-C.Y. and S.-N.W.; Visualization, M.-C.Y., H.-Y.C. and S.-N.W.; Supervision, M.-H.L., J.-F.L., C.-L.W. and S.-N.W.; Project administration, M.-H.L., J.-F.L., C.-L.W. and S.-N.W.; Funding acquisition, M.-H.L., J.-F.L. and S.-N.W. All authors have read and agreed to the published version of the manuscript.
Not applicable.
Not applicable.
The original data is available upon reasonable request to the corresponding author.
The authors thank Hsin-Yen Cho for her contribution to the earlier experiments.
All the authors report no declaration that is directly relevant to this work.
DLT | deltamethrin |
ChloroTx | chlorotoxin |
Dapa | dapagliflozin |
EC50 | concentration required for half-maximal stimulation |
Hys(V) | voltage-dependent hysteresis |
I-V relationship | current versus voltage relationship |
I Na | voltage-gated Na+ current |
I Na(L) | late Na+ current |
I Na(P) | persistent Na+ current |
I Na(Tot) | total Na+ current (i.e., INa(T) plus INa(L)) |
I Na(Tail) | tail Na+ current |
NaV channel | voltage-gated Na+ channel |
PT stimulation | pulse train stimulation |
Tef | tefluthrin |
Vramp | ramp voltage |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figure 1. Effect of deltamethrin (DLT) or tefluthrin (Tef) on voltage-gated Na+ current (INa) measured from pituitary GH3 lactotrophs. This set of experiments was made in cells placed in Ca2+-free, Tyrode’s solution containing 10 mM tetraethylammonium chloride (TEA), and the measuring electrode was filled with an internal solution enriched with Cs+. (A) Exemplar current traces obtained in (a, blue color) the control conditions (i.e., neither DLT nor Tef was present) and during cell exposure to either 10 μM DLT (b, upper, red color) or 10 μM Tef (b, lower, red color). The voltage-clamp protocol is illustrated atop recorded current traces. The graph shown in the right side of (A) denotes the expanded record from the observed current trace (red color) in the presence of 10 μM DLT and the definition of transient Na+ current (INa(T)), late Na+ current (INa(L)), total Na+ current (INa(Tot)), or tail Na+ current (INa(Tail)) is marked (indicated with blue double arrows). (B) Time course of effects of 10 μM DLT on the amplitude of INa(Tot) (upper), INa(L) (middle), and INa(T) (lower). Each point was taken at a rate of 0.1 Hz. The horizontal bar shown above indicated the application of DLT. (C) Concentration-dependent relationship of DLT on INa(T) (purple open circles) or INa(L) (blue solid circles) activated by short depolarizing step. Each data point in this graph represents mean ± SEM of 9 cells. According to the averaged data, the smooth line represents the best fit to the Hill equation as described in Materials and Methods.
Figure 1. Effect of deltamethrin (DLT) or tefluthrin (Tef) on voltage-gated Na+ current (INa) measured from pituitary GH3 lactotrophs. This set of experiments was made in cells placed in Ca2+-free, Tyrode’s solution containing 10 mM tetraethylammonium chloride (TEA), and the measuring electrode was filled with an internal solution enriched with Cs+. (A) Exemplar current traces obtained in (a, blue color) the control conditions (i.e., neither DLT nor Tef was present) and during cell exposure to either 10 μM DLT (b, upper, red color) or 10 μM Tef (b, lower, red color). The voltage-clamp protocol is illustrated atop recorded current traces. The graph shown in the right side of (A) denotes the expanded record from the observed current trace (red color) in the presence of 10 μM DLT and the definition of transient Na+ current (INa(T)), late Na+ current (INa(L)), total Na+ current (INa(Tot)), or tail Na+ current (INa(Tail)) is marked (indicated with blue double arrows). (B) Time course of effects of 10 μM DLT on the amplitude of INa(Tot) (upper), INa(L) (middle), and INa(T) (lower). Each point was taken at a rate of 0.1 Hz. The horizontal bar shown above indicated the application of DLT. (C) Concentration-dependent relationship of DLT on INa(T) (purple open circles) or INa(L) (blue solid circles) activated by short depolarizing step. Each data point in this graph represents mean ± SEM of 9 cells. According to the averaged data, the smooth line represents the best fit to the Hill equation as described in Materials and Methods.
Figure 2. Comparison among effects of Tef, DLT, Tef plus chlorotoxin (ChloroTx), DLT plus ChloroTx, Tef plus dapagliflozin (Dapa), DLT plus Dapa, and DLT plus amiloride on the amplitude of INa(L) measured from GH3 cells. The INa was elicited by 20 ms depolarizing voltage command from −80 to −10 mV for a duration of 20 ms at a rate of 0.2 Hz. The INa(L) amplitudes during exposure to different tested compounds were measured at the end of each depolarizing step. Each bar represents the mean ± SEM (n = 8). * Significantly different from control (p < 0.05), ** significantly different from Tef (10 μM) alone group (p < 0.05), and + significant different from DLT (10 μM) alone group (p < 0.05).
Figure 3. Effect of DLT on the steady-state current versus voltage (I-V) relationship of INa(T) and INa(L) identified from GH3 cells. In this set of experiments, we held each cell at −80 mV, and varying depolarizing command voltages from −80 to +10 mV in 10-mV steps were delivered to evoke INa(T) and INa(L). (A) Exemplar current traces obtained either in the control condition (upper) or with the presence of 10 μM DLT (lower). The uppermost part is the voltage-clamp protocol given. (B) The mean I-V relationship of INa(T) (black symbols) or INa(L) (red symbols) in control (upper, solid symbols) and during exposure to 10 μM DLT (lower, open symbols) (mean ± SEM; n = 8 for each point). Either INa(T) or INa(L) was measured at the beginning or end of each depolarizing pulse. (C) Conductance versus voltage relationship of INa(T) (black symbols) or INa(L) (red symbols) in the control period (left side) and during cell exposure to 10 μM DLT (right side) (mean ± SEM; n = 8 for each point).
Figure 4. Effects of Tef (A) or DLT (B,C) on INa evoked by a train of depolarizing pulses (i.e., pulse train [PT] stimulation) in GH3 cells. The train given consists of 40–20 ms pulses (stepped to −10 mV) separated 5 ms intervals at −80 mV for a total duration of 1 sec. In (A) or (B), exemplar current traces acquired in the control period (i.e., neither Tef nor DLT was present, upper part, blue color) and during cell exposure to 10 μM Tef (lower part, red color) or 10 μM DLT (lower part, red color) are illustrated, respectively. The voltage-clamp protocol (black color) atop current traces in (A–C) is illustrated. The black dashed arrows in (A) or (B), respectively, indicate the direction of current changes (i.e., either decay or rise) over time in an exponential fashion, while the asterisk shows a large inward deflection following PT stimulation with cell exposure to 10 μM Tef (upper) or 10 μM DLT (lower). (C) Expanded records (i.e., potential or current traces) from the broken box in (B).
Figure 4. Effects of Tef (A) or DLT (B,C) on INa evoked by a train of depolarizing pulses (i.e., pulse train [PT] stimulation) in GH3 cells. The train given consists of 40–20 ms pulses (stepped to −10 mV) separated 5 ms intervals at −80 mV for a total duration of 1 sec. In (A) or (B), exemplar current traces acquired in the control period (i.e., neither Tef nor DLT was present, upper part, blue color) and during cell exposure to 10 μM Tef (lower part, red color) or 10 μM DLT (lower part, red color) are illustrated, respectively. The voltage-clamp protocol (black color) atop current traces in (A–C) is illustrated. The black dashed arrows in (A) or (B), respectively, indicate the direction of current changes (i.e., either decay or rise) over time in an exponential fashion, while the asterisk shows a large inward deflection following PT stimulation with cell exposure to 10 μM Tef (upper) or 10 μM DLT (lower). (C) Expanded records (i.e., potential or current traces) from the broken box in (B).
Figure 5. Relationship of INa(T) or INa(Tail) versus the pulse train (PT) duration in the absence (blue filled circles) and presence (orange open circles or blue open triangles) of 10 μM DLT (mean ± SEM, n = 8 for each point). The observed INa(T) or INa(L) was measured as indicated in the right side of Figure 1. The continuous smooth lines, over which the experimental data points are overlaid, were optimally fitted by a single exponential (i.e., exponential decrease or increase). Notably, during PT stimulation, cell exposure to DLT can increase the decaying time constant of INa(T) inactivation; however, it led to a progressive increase (i.e., staircase increase) in the amplitude of INa(Tail).
Figure 6. Effect of DLT or DLT plus Dapa on INa evoked by PT stimulation identified from GH3 cells. The PT stimulation was applied in exactly the same way as utilized in Figure 4. (A) Exemplar current traces obtained in the presence of DLT (10 μM) alone (black color) or DLT (10 μM) plus Dapa (10 μM) (red color). The upper part shows the voltage-clamp protocol (blue color) given, whereas asterisk denotes the emergence of the current recovery immediately following PT stimulation. (B) Summary bar graph demonstrating effects of Tef, DLT, Tef plus Dapa, and DLT plus Dapa on the recovery time constant of INa following PT stimulation (mean ± SEM; n = 8 for each bar). * Significantly different from control (p < 0.01), ** significantly different from Tef (10 μM) alone group (p < 0.05), + significantly different from Tef (10 μM) alone group (p < 0.05), and ++ significantly different from DLT (10 μM) alone group (p < 0.05).
Figure 7. Modifications by Tef or DLT on the strength of voltage-dependent hysteresis (Hys(V)) in persistent INa (INa(P)) present in GH3 cells. In this set of whole-cell current recordings, the examined cell was voltage-clamped at −80 mV and we then delivered the isosceles-triangular ramp voltage (Vramp) for a duration of 1 s (i.e., a ramp speed of ±0.26 mV/ms) to activate INa(P). (A) Exemplar current traces obtained in the control period (upper) and in the presence of 10 μM Tef (middle) or 10 μM DLT (lower). The ascending (upsloping) limb is indicated in black color, where the descending (downsloping) one is in the red color. Inset in the upper part of (A) shows the voltage-clamp protocol applied, whereas the dashed arrow indicates the direction of potential or current trajectory by which time goes. In (B) or (C), summary bar graph, respectively, demonstrates the effect of Tef (10 μM), DLT (10 μM), Tef (10 μM) plus Dapa (10 μM), and DLT (10 μM) plus Dapa (10 μM) on INa(P) amplitude activated by upsloping (at −10 mV) or downsloping limb (at the level of −70 mV) of double Vramp (mean ± SEM; n = 8 for each bar). * Significantly different from control (p < 0.05), ** significantly different from Tef (10 μM) alone group (p < 0.05), and + significantly different from DLT (10 μM) alone group (p < 0.05).
Effects of DLT, DLT plus dapagliflozin (Dapa, 10 mM), and DLT plus amiloride (Ami, 10 mM) on either the decaying time constant of INa(T) during pulse train (PT) stimulation (i.e., cumulative inhibition of INa(T) during rapid depolarizing stimuli) or the rising time constant of INa(L) during the same PT stimulation, as well as the time constant of INa(Tail) recovery evoked following PT stimulation. All values are mean ± SEM.
Control | DLT (10 mM) | DLT (10 mM) Plus Dapa (10 mM) | DLT (10 mM) Plus Ami (10 mM) | Cell Number (n) | |
---|---|---|---|---|---|
Decaying time constant of INa(T) | 22.1 ± 2.8 ms | 56.4 ± 3.9 * ms | 29.6 ± 6.1 * ms | 30.9 ± 6.5 * ms | 8 |
Rising time constant of INa(L) | (-) | 87.4 ± 4.6 ms | 19.1 ± 6.1 ** ms | 21.1 ± 6.5 ** ms | 8 |
Recovery time constant of INa(Tail) | 25 ± 3 ms | 1.23 ± 0.19 + s | 0.56 ± 0.04 ** s | 0.58 ± 0.05 ** s | 8 |
* Significantly different from controls (p < 0.05), ** significantly different from DLT (10 mM) alone groups (p < 0.05), and + significantly different from controls (p < 0.01). (-) shown in
References
1. Laskowski, D.A. Physical and chemical properties of pyrethroids. Rev. Environ. Contam. Toxicol.; 2002; 174, pp. 49-170. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12132343]
2. Bradberry, S.M.; Cage, S.A.; Proudfoot, A.T.; Vale, J.A. Poisoning due to pyrethroids. Toxicol. Rev.; 2005; 24, pp. 93-106. [DOI: https://dx.doi.org/10.2165/00139709-200524020-00003] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/16180929]
3. Dhiman, S.; Yadav, K.; Acharya, B.N.; Nagar, D.P.; Rao Ghorpade, R. Deltamethrin Contact Exposure Mediated Toxicity and Histopathological Aberrations in Tissue Systems of Public Health Importance Cockroach Species Periplaneta americana and Blattella germanica. Front. Physiol.; 2022; 13, 926267. [DOI: https://dx.doi.org/10.3389/fphys.2022.926267]
4. Eads, D.; Livieri, T.; Tretten, T.; Hughes, J.; Kaczor, N.; Halsell, E.; Grassel, S.; Dobesh, P.; Childers, E.; Lucas, D. et al. Assembling a safe and effective toolbox for integrated flea control and plague mitigation: Fipronil experiments with prairie dogs. PLoS ONE; 2022; 17, e0272419. [DOI: https://dx.doi.org/10.1371/journal.pone.0272419]
5. Ma, C.; Wei, D.; Liu, P.; Fan, K.; Nie, L.; Song, Y.; Wang, M.; Wang, L.; Xu, Q.; Wang, J. et al. Pesticide Residues in Commonly Consumed Vegetables in Henan Province of China in 2020. Front. Public Health; 2022; 10, 901485. [DOI: https://dx.doi.org/10.3389/fpubh.2022.901485]
6. Tabarean, I.V.; Narahashi, T. Potent modulation of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels by the type II pyrethroid deltamethrin. J. Pharmacol. Exp. Ther.; 1998; 284, pp. 958-965.
7. Tan, J.; Soderlund, D.M. Divergent actions of the pyrethroid insecticides S-bioallethrin, tefluthrin, and deltamethrin on rat Na(v)1.6 sodium channels. Toxicol. Appl. Pharmacol.; 2010; 247, pp. 229-237. [DOI: https://dx.doi.org/10.1016/j.taap.2010.07.001] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20624410]
8. McCavera, S.J.; Soderlund, D.M. Differential state-dependent modification of inactivation-deficient Nav1.6 sodium channels by the pyrethroid insecticides S-bioallethrin, tefluthrin and deltamethrin. Neurotoxicology; 2012; 33, pp. 384-390. [DOI: https://dx.doi.org/10.1016/j.neuro.2012.03.007]
9. James, T.F.; Nenov, M.N.; Tapia, C.M.; Lecchi, M.; Koshy, S.; Green, T.A.; Laezza, F. Consequences of acute Na(v)1.1 exposure to deltamethrin. Neurotoxicology; 2017; 60, pp. 150-160. [DOI: https://dx.doi.org/10.1016/j.neuro.2016.12.005]
10. So, E.C.; Wu, S.N.; Lo, Y.C.; Su, K. Differential regulation of tefluthrin and telmisartan on the gating charges of I(Na) activation and inactivation as well as on resurgent and persistent INa in a pituitary cell line (GH3). Toxicol. Lett.; 2018; 285, pp. 104-112. [DOI: https://dx.doi.org/10.1016/j.toxlet.2018.01.002]
11. Breckenridge, C.B.; Holden, L.; Sturgess, N.; Weiner, M.; Sheets, L.; Sargent, D.; Soderlund, D.M.; Choi, J.S.; Symington, S.; Clark, J.M. et al. Evidence for a separate mechanism of toxicity for the Type I and the Type II pyrethroid insecticides. Neurotoxicology; 2009; 30, (Suppl. 1), pp. S17-S31. [DOI: https://dx.doi.org/10.1016/j.neuro.2009.09.002] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/19766671]
12. Chrustek, A.; Hołyńska-Iwan, I.; Dziembowska, I.; Bogusiewicz, J.; Wróblewski, M.; Cwynar, A.; Olszewska-Słonina, D. Current Research on the Safety of Pyrethroids Used as Insecticides. Medicina; 2018; 54, 61. [DOI: https://dx.doi.org/10.3390/medicina54040061]
13. Williams, M.T.; Gutierrez, A.; Vorhees, C.V. Effects of Acute Deltamethrin Exposure in Adult and Developing Sprague Dawley Rats on Acoustic Startle Response in Relation to Deltamethrin Brain and Plasma Concentrations. Toxicol. Sci.; 2019; 168, pp. 61-69. [DOI: https://dx.doi.org/10.1093/toxsci/kfy275] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30395337]
14. Forshaw, P.J.; Lister, T.; Ray, D.E. Inhibition of a neuronal voltage-dependent chloride channel by the type II pyrethroid, deltamethrin. Neuropharmacology; 1993; 32, pp. 105-111. [DOI: https://dx.doi.org/10.1016/0028-3908(93)90089-L]
15. Burr, S.A.; Ray, D.E. Structure-activity and interaction effects of 14 different pyrethroids on voltage-gated chloride ion channels. Toxicol. Sci.; 2004; 77, pp. 341-346. [DOI: https://dx.doi.org/10.1093/toxsci/kfh027] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/14657519]
16. Hołyńska-Iwan, I.; Bogusiewicz, J.; Chajdas, D.; Szewczyk-Golec, K.; Lampka, M.; Olszewska-Słonina, D. The immediate influence of deltamethrin on ion transport through rabbit skin. An in vitro study. Pestic. Biochem. Physiol.; 2018; 148, pp. 144-150. [DOI: https://dx.doi.org/10.1016/j.pestbp.2018.04.011] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29891365]
17. Costa, L.G. The neurotoxicity of organochlorine and pyrethroid pesticides. Handb. Clin. Neurol.; 2015; 131, pp. 135-148. [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/26563787]
18. Van Goor, F.; Zivadinovic, D.; Stojilkovic, S.S. Differential expression of ionic channels in rat anterior pituitary cells. Mol. Endocrinol.; 2001; 15, pp. 1222-1236. [DOI: https://dx.doi.org/10.1210/mend.15.7.0668]
19. Jukič, M.; Kikelj, D.; Anderluh, M. Isoform selective voltage-gated sodium channel modulators and the therapy of pain. Curr. Med. Chem.; 2014; 21, pp. 164-186. [DOI: https://dx.doi.org/10.2174/09298673113206660257]
20. Guérineau, N.C.; Monteil, A.; Lory, P. Sodium background currents in endocrine/neuroendocrine cells: Towards unraveling channel identity and contribution in hormone secretion. Front. Neuroendocrinol.; 2021; 63, 100947. [DOI: https://dx.doi.org/10.1016/j.yfrne.2021.100947]
21. Catterall, W.A. Forty Years of Sodium Channels: Structure, Function, Pharmacology, and Epilepsy. Neurochem. Res.; 2017; 42, pp. 2495-2504. [DOI: https://dx.doi.org/10.1007/s11064-017-2314-9] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28589518]
22. Taddese, A.; Bean, B.P. Subthreshold sodium current from rapidly inactivating sodium channels drives spontaneous firing of tuberomammillary neurons. Neuron; 2002; 33, pp. 587-600. [DOI: https://dx.doi.org/10.1016/S0896-6273(02)00574-3] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/11856532]
23. Huang, C.W.; Hung, T.Y.; Wu, S.N. The inhibitory actions by lacosamide, a functionalized amino acid, on voltage-gated Na+ currents. Neuroscience; 2015; 287, pp. 125-136. [DOI: https://dx.doi.org/10.1016/j.neuroscience.2014.12.026] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25534720]
24. Navarro, M.A.; Salari, A.; Lin, J.L.; Cowan, L.M.; Penington, N.J.; Milescu, M.; Milescu, L.S. Sodium channels implement a molecular leaky integrator that detects action potentials and regulates neuronal firing. Elife; 2020; 9, e54940. [DOI: https://dx.doi.org/10.7554/eLife.54940]
25. Wu, P.M.; Lai, P.C.; Cho, H.Y.; Chuang, T.H.; Wu, S.N.; Tu, Y.F. Effective Perturbations by Phenobarbital on I(Na), I(K(erg)), I(K(M)) and I(K(DR)) during Pulse Train Stimulation in Neuroblastoma Neuro-2a Cells. Biomedicines; 2022; 10, 1968. [DOI: https://dx.doi.org/10.3390/biomedicines10081968]
26. Wu, S.N.; Chen, B.S.; Hsu, T.I.; Peng, H.; Wu, Y.H.; Lo, Y.C. Analytical studies of rapidly inactivating and noninactivating sodium currents in differentiated NG108-15 neuronal cells. J. Theor. Biol.; 2009; 259, pp. 828-836. [DOI: https://dx.doi.org/10.1016/j.jtbi.2009.05.003]
27. Stojilkovic, S.S.; Bjelobaba, I.; Zemkova, H. Ion Channels of Pituitary Gonadotrophs and Their Roles in Signaling and Secretion. Front. Endocrinol.; 2017; 8, 126. [DOI: https://dx.doi.org/10.3389/fendo.2017.00126]
28. Zhang, J.; Chen, X.; Eaton, M.; Wu, J.; Ma, Z.; Lai, S.; Park, A.; Ahmad, T.S.; Que, Z.; Lee, J.H. et al. Severe deficiency of the voltage-gated sodium channel Na(V)1.2 elevates neuronal excitability in adult mice. Cell Rep.; 2021; 36, 109495. [DOI: https://dx.doi.org/10.1016/j.celrep.2021.109495]
29. Hsu, C.L.; Zhao, X.; Milstein, A.D.; Spruston, N. Persistent Sodium Current Mediates the Steep Voltage Dependence of Spatial Coding in Hippocampal Pyramidal Neurons. Neuron; 2018; 99, pp. 147-162.e8. [DOI: https://dx.doi.org/10.1016/j.neuron.2018.05.025]
30. Gutiérrez, Y.; Tomé, H.V.V.; Guedes, R.N.C.; Oliveira, E.E. Deltamethrin toxicity and impaired swimming behavior of two backswimmer species. Environ. Toxicol. Chem.; 2017; 36, pp. 1235-1242. [DOI: https://dx.doi.org/10.1002/etc.3645]
31. Vega, A.V.; Espinosa, J.L.; López-Domínguez, A.M.; López-Santiago, L.F.; Navarrete, A.; Cota, G. L-type calcium channel activation up-regulates the mRNAs for two different sodium channel alpha subunits (Nav1.2 and Nav1.3) in rat pituitary GH3 cells. Brain Res. Mol. Brain Res.; 2003; 116, pp. 115-125. [DOI: https://dx.doi.org/10.1016/S0169-328X(03)00279-1] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/12941467]
32. Philippaert, K.; Kalyaanamoorthy, S.; Fatehi, M.; Long, W.; Soni, S.; Byrne, N.J.; Barr, A.; Singh, J.; Wong, J.; Palechuk, T. et al. Cardiac Late Sodium Channel Current Is a Molecular Target for the Sodium/Glucose Cotransporter 2 Inhibitor Empagliflozin. Circulation; 2021; 143, pp. 2188-2204. [DOI: https://dx.doi.org/10.1161/CIRCULATIONAHA.121.053350] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/33832341]
33. Wu, S.N.; Wu, C.L.; Cho, H.Y.; Chiang, C.W. Effective Perturbations by Small-Molecule Modulators on Voltage-Dependent Hysteresis of Transmembrane Ionic Currents. Int. J. Mol. Sci.; 2022; 23, 9453. [DOI: https://dx.doi.org/10.3390/ijms23169453] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/36012718]
34. Tsai, D.; Morley, J.W.; Suaning, G.J.; Lovell, N.H. Frequency-dependent reduction of voltage-gated sodium current modulates retinal ganglion cell response rate to electrical stimulation. J. Neural Eng.; 2011; 8, 066007. [DOI: https://dx.doi.org/10.1088/1741-2560/8/6/066007] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/22027396]
35. Muralidharan, M.; Guo, T.; Shivdasani, M.N.; Tsai, D.; Fried, S.; Li, L.; Dokos, S.; Morley, J.W.; Lovell, N.H. Neural activity of functionally different retinal ganglion cells can be robustly modulated by high-rate electrical pulse trains. J. Neural Eng.; 2020; 17, 045013. [DOI: https://dx.doi.org/10.1088/1741-2552/ab9a97]
36. Shiau, A.L.; Liao, C.S.; Tu, C.W.; Wu, S.N.; Cho, H.Y.; Yu, M.C. Characterization in Effective Stimulation on the Magnitude, Gating, Frequency Dependence, and Hysteresis of I(Na) Exerted by Picaridin (or Icaridin), a Known Insect Repellent. Int. J. Mol. Sci.; 2022; 23, 9696. [DOI: https://dx.doi.org/10.3390/ijms23179696]
37. Xue, N.; Li, F.; Hou, H.; Li, B. Occurrence of endocrine-disrupting pesticide residues in wetland sediments from Beijing, China. Environ. Toxicol. Chem.; 2008; 27, pp. 1055-1062. [DOI: https://dx.doi.org/10.1897/07-511.1]
38. Eni, G.; Ibor, O.R.; Andem, A.B.; Oku, E.E.; Chukwuka, A.V.; Adeogun, A.O.; Arukwe, A. Biochemical and endocrine-disrupting effects in Clarias gariepinus exposed to the synthetic pyrethroids, cypermethrin and deltamethrin. Comp. Biochem. Physiol. C Toxicol. Pharmacol.; 2019; 225, 108584. [DOI: https://dx.doi.org/10.1016/j.cbpc.2019.108584]
39. Hołyńska-Iwan, I.; Szewczyk-Golec, K. Pyrethroids: How They Affect Human and Animal Health?. Medicina; 2020; 56, 582. [DOI: https://dx.doi.org/10.3390/medicina56110582]
40. Knapke, E.T.; Magalhaes, D.P.; Dalvie, M.A.; Mandrioli, D.; Perry, M.J. Environmental and occupational pesticide exposure and human sperm parameters: A Navigation Guide review. Toxicology; 2022; 465, 153017. [DOI: https://dx.doi.org/10.1016/j.tox.2021.153017]
41. Yang, Y.; Wang, C.; Shen, H.; Fan, H.; Liu, J.; Wu, N. Cis-bifenthrin inhibits cortisol and aldosterone biosynthesis in human adrenocortical H295R cells via cAMP signaling cascade. Environ. Toxicol. Pharmacol.; 2022; 89, 103784. [DOI: https://dx.doi.org/10.1016/j.etap.2021.103784] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/34896276]
42. Kim, K.B.; Anand, S.S.; Kim, H.J.; White, C.A.; Fisher, J.W.; Tornero-Velez, R.; Bruckner, J.V. Age, dose, and time-dependency of plasma and tissue distribution of deltamethrin in immature rats. Toxicol Sci.; 2010; 115, pp. 354-368. [DOI: https://dx.doi.org/10.1093/toxsci/kfq074] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/20211939]
43. Chi, C.C.; Chou, C.T.; Liang, W.Z.; Jan, C.R. Effect of the pesticide, deltamethrin, on Ca2+ signaling and apoptosis in OC2 human oral cancer cells. Drug. Chem. Toxicol.; 2014; 37, pp. 25-31. [DOI: https://dx.doi.org/10.3109/01480545.2013.806528] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/23829777]
44. Kumar, A.; Sasmal, D.; Sharma, N.; Bhaskar, A.; Chandra, S.; Mukhopadhyay, K.; Kumar, M. Deltamethrin, a pyrethroid insecticide, could be a promising candidate as an anticancer agent. Med. Hypotheses; 2015; 85, pp. 145-147. [DOI: https://dx.doi.org/10.1016/j.mehy.2015.04.018] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/25981874]
45. Klumpp, L.; Sezgin, E.C.; Eckert, F.; Huber, S.M. Ion Channels in Brain Metastasis. Int. J. Mol. Sci.; 2016; 17, 1513. [DOI: https://dx.doi.org/10.3390/ijms17091513] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27618016]
46. Lee, H.H.; Chou, C.T.; Liang, W.Z.; Chen, W.C.; Wang, J.L.; Yeh, J.H.; Kuo, C.C.; Shieh, P.; Kuo, D.H.; Chen, F.A. et al. Ca2+ Movement Induced by Deltamethrin in PC3 Human Prostate Cancer Cells. Chin. J. Physiol.; 2016; 59, pp. 148-155. [DOI: https://dx.doi.org/10.4077/CJP.2016.BAE386] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/27188467]
47. Sharma, N.; Banerjee, S.; Mazumder, P.M. Evaluation of the mechanism of anticancer activity of deltamethrin in Jurkat-J6 cell line. Pestic. Biochem. Physiol.; 2018; 149, pp. 98-103. [DOI: https://dx.doi.org/10.1016/j.pestbp.2018.06.010] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/30033023]
48. Han, B.; Lv, Z.; Zhang, X.; Lv, Y.; Li, S.; Wu, P.; Yang, Q.; Li, J.; Qu, B.; Zhang, Z. Deltamethrin induces liver fibrosis in quails via activation of the TGF-β1/Smad signaling pathway. Environ. Pollut.; 2020; 259, 113870. [DOI: https://dx.doi.org/10.1016/j.envpol.2019.113870]
49. Sontheimer, H.; Black, J.A.; Waxman, S.G. Voltage-gated Na+ channels in glia: Properties and possible functions. Trends Neurosci.; 1996; 19, pp. 325-331. [DOI: https://dx.doi.org/10.1016/0166-2236(96)10039-4]
50. Rizaner, N.; Onkal, R.; Fraser, S.P.; Pristerá, A.; Okuse, K.; Djamgoz, M.B. Intracellular calcium oscillations in strongly metastatic human breast and prostate cancer cells: Control by voltage-gated sodium channel activity. Eur. Biophys. J.; 2016; 45, pp. 735-748. [DOI: https://dx.doi.org/10.1007/s00249-016-1170-x]
51. Gumushan Aktas, H.; Akgun, T. Naringenin inhibits prostate cancer metastasis by blocking voltage-gated sodium channels. Biomed. Pharmacother.; 2018; 106, pp. 770-775. [DOI: https://dx.doi.org/10.1016/j.biopha.2018.07.008] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/29990870]
52. Lai, M.C.; Tzeng, R.C.; Huang, C.W.; Wu, S.N. The Novel Direct Modulatory Effects of Perampanel, an Antagonist of AMPA Receptors, on Voltage-Gated Sodium and M-type Potassium Currents. Biomolecules; 2019; 9, 638. [DOI: https://dx.doi.org/10.3390/biom9100638] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/31652643]
53. Varró, P.; Kovács, M.; Világi, I. The insecticide esfenvalerate modulates neuronal excitability in mammalian central nervous system in vitro. Toxicol. Lett.; 2017; 267, pp. 39-44. [DOI: https://dx.doi.org/10.1016/j.toxlet.2016.12.012] [PubMed: https://www.ncbi.nlm.nih.gov/pubmed/28007640]
54. Baron, S.; Barrero, R.A.; Black, M.; Bellgard, M.I.; van Dalen, E.M.S.; Fourie, J.; Maritz-Olivier, C. Differentially expressed genes in response to amitraz treatment suggests a proposed model of resistance to amitraz in R. decoloratus ticks. Int. J. Parasitol. Drugs Drug. Resist.; 2018; 8, pp. 361-371. [DOI: https://dx.doi.org/10.1016/j.ijpddr.2018.06.005]
55. Pitzer, E.M.; Sugimoto, C.; Gudelsky, G.A.; Huff Adams, C.L.; Williams, M.T.; Vorhees, C.V. Deltamethrin Exposure Daily From Postnatal Day 3-20 in Sprague-Dawley Rats Causes Long-term Cognitive and Behavioral Deficits. Toxicol. Sci.; 2019; 169, pp. 511-523. [DOI: https://dx.doi.org/10.1093/toxsci/kfz067]
56. Carpenter, J.M.; Brown, K.A.; Diaz, A.N.; Dockman, R.L.; Benbow, R.A.; Harn, D.A.; Norberg, T.; Wagner, J.J.; Filipov, N.M. Delayed treatment with the immunotherapeutic LNFPIII ameliorates multiple neurological deficits in a pesticide-nerve agent prophylactic mouse model of Gulf War Illness. Neurotoxicol. Teratol.; 2021; 87, 107012. [DOI: https://dx.doi.org/10.1016/j.ntt.2021.107012]
57. Cassano, G.; Bellantuono, V.; Ardizzone, C.; Lippe, C. Pyrethroid stimulation of ion transport across frog skin. Environ. Toxicol. Chem.; 2003; 22, pp. 1330-1334. [DOI: https://dx.doi.org/10.1002/etc.5620220620]
58. Peng, C.-C.; Li, Y.-R. Parameters Identification of Nonlinear Lorenz Chaotic System and its Application to High Precision Model Reference Synchronization. Res. Sq.; 2021; [DOI: https://dx.doi.org/10.21203/rs.3.rs-808004/v1]
59. Cho, H.Y.; Chuang, T.H.; Wu, S.N. Effective Perturbations on the Amplitude and Hysteresis of Erg-Mediated Potassium Current Caused by 1-Octylnonyl 8-[(2-hydroxyethyl)[6-oxo-6(undecyloxy)hexyl]amino]-octanoate (SM-102), a Cationic Lipid. Biomedicines; 2021; 9, 1367. [DOI: https://dx.doi.org/10.3390/biomedicines9101367]
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Abstract
Deltamethrin (DLT) is a type-II pyrethroid ester insecticide used in agricultural and domestic applications as well as in public health. However, transmembrane ionic channels perturbed by this compound remain largely unclear, although the agent is thought to alter the gating characteristics of voltage-gated Na+ (NaV) channel current. In this study, we reappraised whether and how it and other related compounds can make any further modifications on voltage-gated Na+ current (INa) in pituitary tumor (GH3) cells. Cell exposure to DLT produced a differential and dose-dependent stimulation of peak (transient, INa(T)) or sustained (late, INa(L)) INa; consequently, the EC50 value required for DLT-stimulated INa(T) or INa(L) was determined to be 11.2 or 2.5 μM, respectively. However, neither the fast nor slow component in the inactivation time constant of INa(T) activated by short depolarizing pulse was changed with the DLT presence; conversely, tefluthrin (Tef), a type-I pyrethroid insecticide, can accentuate INa with a slowing in inactivation time course of the current. The INa(L) augmented by DLT was attenuated by further application of either dapagliflozin (Dapa) or amiloride, but not by chlorotoxin. During pulse train (PT) stimulation, with the Tef or DLT presence, the cumulative inhibition of INa(T) became slowed; moreover, following PT stimuli, a large tail current with a slowly recovering process was observed. Alternatively, during rapid depolarizing pulse, the amplitude of INa(L) and tail INa (INa(Tail)) for each depolarizing pulse became progressively increased by adding DLT, not by Tef. The recovery time constant following PT stimulation with continued presence of Tef or DLT was shortened by further addition of Dapa. The voltage-dependent hysteresis (Hys(V)) of persistent INa was differentially augmented by Tef or DLT. Taken together, the magnitude, gating, frequency dependence, as well as Hys(V) behavior of INa exerted by the presence of DLT or Tef might exert a synergistic impact on varying functional activities of excitable cells in culture or in vivo.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 Division of Neurology, Department of Internal Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City 600, Taiwan
2 Department of Emergency Medicine, Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City 600, Taiwan
3 Department of Physiology, National Cheng Kung University Medical College, Tainan 701, Taiwan
4 Department of Physiology, National Cheng Kung University Medical College, Tainan 701, Taiwan; Institute of Basic Medical Sciences, National Cheng Kung University Medical College, Tainan 701, Taiwan; Department of Post-Baccalaureate Medicine, National Sun Yat-Sen University, Kaohsiung 804, Taiwan
5 Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City 600, Taiwan